Bulletin
Investor Alert

New York Markets Open in:

Market Pulse Archives

July 19, 2018, 7:51 a.m. EDT

Biotech Allakos prices IPO at $18, above price range

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Allakos Inc. (ALLK)

or Cancel Already have a watchlist? Log In

By Ciara Linnane

ALLK

Biotech Allakos Inc. /zigman2/quotes/203639566/composite ALLK -4.91% priced its initial public offering at $18 a share, above its $15 to $17 price range. The clinical-stage company, which focuses on developing antibodies for the treatment of eosinophil and mast cell related diseases, sold 7.1 million shares to raise $127.8 million. Shares will start trading later Thursday on Nasdaq, under the ticker symbol "ALLK."

/zigman2/quotes/203639566/composite
US : U.S.: Nasdaq
$ 6.20
-0.32 -4.91%
Volume: 1.37M
Jan. 27, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$354.12 million
Rev. per Employee
N/A
loading...

Get news alerts on Allakos Inc. — or create your own.
This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.